Plasmid DNA Manufacturing Services Market
Plasmid DNA Manufacturing Services Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Plasmid DNA Manufacturing Services Market Size and Growth
The Plasmid DNA Manufacturing Services market is witnessing significant growth, driven by increasing demand for gene therapies and vaccines. The market size is projected to reach approximately $500 million by 2026, reflecting a CAGR of over 15%. Key trends include advancements in production technologies and rising investments in biotech research.
Companies Covered
(Covid 19 Impact Covered)
◍ Vigene Biosciences
◍ Aldevron
◍ Creative Biogene
◍ Thermo Fisher Scientific Inc.
◍ Kaneka Eurogentec SA
◍ AGC Biologics
◍ Andelyn Biosciences
◍ Biomay
◍ VGXI, Inc.
◍ VectorBuilder
◍ Xpress Biologics
◍ Biovian
◍ WuXi Advanced Therapies
◍ Catalent, Inc
◍ Charles River Laboratories
◍ Esco Aster Pte. Ltd
◍ Waisman
◍ Boehringer Ingelheim
The plasmid DNA manufacturing services market features key players like Vigene Biosciences, Aldevron, and Thermo Fisher Scientific, offering services for gene therapy and vaccine development. These companies enhance market growth by providing scalable production solutions. Sales revenues include: Aldevron ($120M), Thermo Fisher ($39B), and Catalent ($4B).
GmbH
Request Sample Report
Market Segmentation
By Application
◍ Medical Industry
◍ Biological Industry
◍ Others
By Product
◍ Research-Grade Plasmids
◍ High Quality (HQ) / GMP-Ready™ Plasmids
◍ CGMP Plasmid
◍ Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
